Correlation Between Pfizer and Instituto Rosenbusch

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Instituto Rosenbusch at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Instituto Rosenbusch into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Instituto Rosenbusch SA, you can compare the effects of market volatilities on Pfizer and Instituto Rosenbusch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Instituto Rosenbusch. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Instituto Rosenbusch.

Diversification Opportunities for Pfizer and Instituto Rosenbusch

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Instituto is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Instituto Rosenbusch SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instituto Rosenbusch and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Instituto Rosenbusch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instituto Rosenbusch has no effect on the direction of Pfizer i.e., Pfizer and Instituto Rosenbusch go up and down completely randomly.

Pair Corralation between Pfizer and Instituto Rosenbusch

Assuming the 90 days trading horizon Pfizer Inc is expected to generate 0.37 times more return on investment than Instituto Rosenbusch. However, Pfizer Inc is 2.71 times less risky than Instituto Rosenbusch. It trades about 0.28 of its potential returns per unit of risk. Instituto Rosenbusch SA is currently generating about -0.18 per unit of risk. If you would invest  740,000  in Pfizer Inc on October 20, 2024 and sell it today you would earn a total of  43,000  from holding Pfizer Inc or generate 5.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.0%
ValuesDaily Returns

Pfizer Inc  vs.  Instituto Rosenbusch SA

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Instituto Rosenbusch 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Instituto Rosenbusch SA are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Instituto Rosenbusch sustained solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Instituto Rosenbusch Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Instituto Rosenbusch

The main advantage of trading using opposite Pfizer and Instituto Rosenbusch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Instituto Rosenbusch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instituto Rosenbusch will offset losses from the drop in Instituto Rosenbusch's long position.
The idea behind Pfizer Inc and Instituto Rosenbusch SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories